(Q34162207)

31 July 2017

1 reference

title

Pathogenesis of hepatocellular carcinoma. (English)

1 reference

31 July 2017

0 references

Macdonald GA

1

1 reference

31 July 2017

1 February 2001

1 reference

31 July 2017

Clinics in liver disease

1 reference

31 July 2017

5

1 reference

31 July 2017

69-85

1 reference

31 July 2017

1

1 reference

Iron-induced oxidative DNA damage and its repair in primary rat hepatocyte culture.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Excess risk of primary liver cancer in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Cancer risk in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Clonal analysis of precancerous lesion of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: a 25-year necropsy review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Computer program for the analysis of mutational spectra: application to p53 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

NIH conference. Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatocellular carcinoma mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

p73 is up-regulated in a subset of hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomerase activity and telomere length in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatocellular carcinoma in liver cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Possible role of oxidative damage in metal-induced carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Microsatellite instability in human hepatocellular carcinoma: relationship to p53 abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomerase activity in hepatocellular carcinoma and adjacent liver tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Diabetes mellitus and the risk of primary liver cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatitis B vaccination and hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Activation of p53 tumor suppressor by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

New link found between p53 and DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Insulin-like growth factor II receptor as a multifunctional binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Comprehensive allelotyping of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Cloning and increased expression of an insulin receptor substrate - 1-like gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Transcriptional repression of p53 promoter by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Microsatellite instability in European hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Telomere length in human liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Nuclear factor kappaB and hepatitis C--Is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

Chromosomal aberrations in hepatocellular carcinomas: Relationship with pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970154-9

7 January 2021

10.1016/S1089-3261(05)70154-9

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11218920